EUVIMEDEUVIMED entdecken
Crossref

Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer

Chengcheng Fan, Shengying Lou, Chenjun Shen, Jialing Liao, Hao Ni, Siyu Chen, Zhihui Zhu, Xueping Hu, Wei Xie, Huajun Zhao, Sunliang Cui iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00872 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Chengcheng Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Triple Negative Breast Neoplasms, Naphthoquinones, Biological Products. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Zhejiang University, National Program for Support of Top-notch Young Professionals, Key Research and Development Program of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and STAT3 has emerged as an effective drug target for TNBC treatment. Herein, we employed a scaffold-hopping strategy of natural products to develop a series of naphthoquinone-furopiperidine derivatives as novel STAT3 inhibitors. The in vitro assay showed that compound 10g possessed higher antiproliferative activity than Cryptotanshinone and Napabucasin against TNBC cell lines, along with lower toxicity and potent antitumor activity in a TNBC xenograft model. Mechanistically, 10g could inhibit the phosphorylation of STAT3 and the binding affinity was determined by the SPR assay (KD = 8.30 μM). Molecule docking studies suggested a plausible binding mode between 10g and the SH2 domain, in which the piperidine fragment and the terminal hydroxy group of 10g played an important role in demonstrating the success of this evolution strategy. These findings provide a natural product-inspired novel STAT3 inhibitor for TNBC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorTriple Negative Breast NeoplasmsNaphthoquinonesBiological ProductsPiperidinesAntineoplastic AgentsCell ProliferationMolecular Docking SimulationHumansAnimalsFemaleCell Line, TumorMiceStructure-Activity RelationshipMice, NudeXenograft Model Antitumor AssaysDrug DiscoveryMice, Inbred BALB CDrug Screening Assays, Antitumor

Substanzen

STAT3 Transcription FactorNaphthoquinonesBiological ProductsPiperidinesSTAT3 protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
  • College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China.
  • Institute of Frontier Chemistry, School of Chemistry and Chemical Engineering, Shandong University, Qingdao 266237, China.

ORCID-Profile: Sunliang Cui

Förderung

  • Zhejiang University
  • National Program for Support of Top-notch Young Professionals
  • Key Research and Development Program of Zhejiang Province
  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Huahai Pharmaceutical Co, LtD.

Zitieren

APA

Fan, C., Lou, S., Shen, C., Liao, J., Ni, H., Chen, S., Zhu, Z., Hu, X., Xie, W., Zhao, H., & Cui, S. (2024). Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00872

Vancouver

Fan C, Lou S, Shen C, Liao J, Ni H, Chen S, et al. Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00872

BibTeX
@article{Fan2024,
  author = {Fan, Chengcheng and Lou, Shengying and Shen, Chenjun and Liao, Jialing and Ni, Hao and Chen, Siyu and Zhu, Zhihui and Hu, Xueping and Xie, Wei and Zhao, Huajun and Cui, Sunliang},
  title = {Natural Product-Inspired Discovery of Naphthoquinone-Furo-Piperidine Derivatives as Novel STAT3 Inhibitors for the Treatment of Triple-Negative Breast Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00872}
}
Kostenlos starten →